Skip to main content
TipRanks
Go Ultimate75% OFF

ReposiTrak (TRAK) Stock Price & Analysis

150 Followers

TRAK Stock Chart & Stats

$7.27-$0.05(-0.68%)
At close: 4:00 PM EST
$7$7.5$8$8.5Aug 24Sep 8Sep 21Oct 5Oct 19Nov 2Nov 16
Day’s Range
$7.09 - $7.67
52-Week Range
$6.61 - $15.10
Previous Close
$7.32
Volume
N/A
Average Volume (3M)
86.18K
Market Cap
$132.32M
Enterprise Value
$142.75M
Total Cash (Recent Filing)
$27.26M
Total Debt (Recent Filing)
$294.34K
Price to Earnings (P/E)
17.9
Beta
1.33
Next Earnings
Feb 16, 2027 (Est.)
Dividend Yield
1.10%

Bulls Say, Bears Say

Bulls Say

Conservative Balance Sheet

The exceptionally low debt burden gives ReposiTrak substantial financial flexibility and limits interest-related pressure on earnings. A strong equity base and growing assets should help the company fund product expansion, absorb volatility, and preserve strategic options over the next several quarters.

Strong Cash Generation And Margins

High margins and free cash flow that closely tracks net income indicate that reported profitability is converting into usable cash. This supports continued investment in growth initiatives, shareholder returns, and operating resilience without requiring substantial external financing.

Platform-led Growth Opportunities

The common platform can support additional services without significantly increasing costs, while SPAR's field organization expands distribution and implementation reach. Pilot conversions, cross-selling, and regulatory traceability demand create several pathways for recurring growth.

Bears Say

Recent Revenue Contraction

The latest revenue decline shows that demand conversion remains uneven despite the longer-term opportunity. Management attributed part of the weakness to the FDA deadline extension delaying customer decisions, which may continue to make near-term growth dependent on timing and rollout execution.

Lower Operating Profitability

Lower operating income and margin indicate that the recent revenue softness is affecting earnings leverage, even though the business remains profitable. If higher operating expenses persist while new initiatives scale, margin recovery could take longer and reduce near-term earnings growth.

Personnel Capacity Constraint

A shortage of available personnel can limit how quickly ReposiTrak converts pilots and customer opportunities into revenue. Careful resource allocation may protect execution quality, but it also creates a structural bottleneck that could delay expansion across Touchless Retail and traceability.

ReposiTrak News

TRAK FAQ

What was ReposiTrak’s price range in the past 12 months?
ReposiTrak lowest stock price was $6.61 and its highest was $15.10 in the past 12 months.
What is ReposiTrak’s market cap?
ReposiTrak’s market cap is $132.32M.
When is ReposiTrak’s upcoming earnings report date?
ReposiTrak’s next earnings report is estimated for Feb 16, 2027 (not yet confirmed), which is in 90 days.
How were ReposiTrak’s earnings last quarter?
ReposiTrak released its earnings results on Nov 16, 2026. The company reported $0.08 earnings per share for the quarter.
Is ReposiTrak overvalued?
According to Wall Street analysts ReposiTrak’s price is currently Undervalued.
Does ReposiTrak pay dividends?
ReposiTrak pays a quarterly dividend of $0.02 which represents an annual dividend yield of 1.1%. See more information on ReposiTrak dividends here
What is ReposiTrak’s EPS estimate?
ReposiTrak’s EPS estimate is 0.07.
How many shares outstanding does ReposiTrak have?
ReposiTrak has 18,201,204 shares outstanding.
What happened to ReposiTrak’s price movement after its last earnings report?
ReposiTrak reported an EPS of $0.08 in its last earnings report. Following the earnings report the stock price went same ―.
Which hedge fund is a major shareholder of ReposiTrak?
Hedge funds hold ReposiTrak shares: the largest hedge-fund position in ReposiTrak is 72,328,443 shares, and hedge funds increased their holdings by 87.2K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology